Lumbar RadiculopathyNCT07743424
Effect of Trans-spinal Electromagnetic Neuromodulation in Treatment of Patients With Discogenic Lumbosacral Radiculopathy
A study testing Trans-spinal Electromagnetic Neuromodulation and Conventional physical therapy in people with Lumbar Radiculopathy and Discogenic Lumbosacral Radiculopathy, run by Yara Aboelazm Abd Elaziz Mohamed at 1 site in Egypt.
Trial summary
Purposes of the study To investigate the effect of adding Trans-spinal Electromagnetic Neuromodulation to conventional physical therapy in patients with Discogenic Lumbosacral Radiculopathy Read more about this study
- Who is it for?
- Ages 20 to 40 years
- Conditions the study is for
- Lumbar Radiculopathy, Discogenic Lumbosacral Radiculopathy
- What is being tested?
- Trans-spinal Electromagnetic Neuromodulation and Conventional physical therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 10 Sep 2026to 10 Feb 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- patient age range from 20 -40 from both sexes.
- Unilateral chronic lumbosacral radiculopathy confirmed by neurosurgeon for more than 3 months.
- Unilateral paracentral or lateral intervertebral disc herniation confirmed by MRI .
- one of the following:
- H- reflex amplitude side to side difference 67% in absence of latency difference.
- H- reflex amplitude side to side difference smaller than 50% in presence of latency difference.
- c - Side to side H- reflex latency difference more than 1 msec. d- Prolonged H-reflex latency more than 30 msec.
Who cannot join
- Hypertension
- Diabetes.
- Lumbar canal stenosis
- Pervious surgeries
- Scoliosis
- Kyphosis
- Spinal fracture
- Bilateral symptoms.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Outpatient Clinic at the Faculty of Physical Therapy Cairo
Giza
Yara Aboelazm, MSc, +201008615584, asiaadam135@gmail.com
About this study
Official title: Effect of Trans-spinal Electromagnetic Neuromodulation on Pain, Functional Outcome and Motor Evoked Potential in Patients With Discogenic Lumbosacral Radiculopathy
Purposes of the study
To investigate the effect of adding Trans-spinal Electromagnetic Neuromodulation to conventional physical therapy in patients with Discogenic Lumbosacral Radiculopathy
Read the detailed description
Patients will be randomized into either Trans-spinal Electromagnetic Neuromodulation group or Conventional physical therapy group. Patients will receive the intervention for six weeks. Outcomes will be assessed at baseline and post-intervention.
- Being tested
- Trans-spinal Electromagnetic Neuromodulation, Conventional physical therapy
- Medical subject headings
- Radiculopathy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Trans-spinal Electromagnetic NeuromodulationOther
Trans-spinal electromagnetic neuromodulation will be applied for 15 minutes on the affected segment
Conventional physical therapyOther
Conventional physical therapy consisting of:
Hot pack on lumbar spine. Neurodynamic mobilization. Rotatory mobilization and rotatory manipulation for lumbar spine. Core stability exercises.
| Study group | Role | What they receive |
|---|---|---|
| Trans-spinal Electromagnetic Neuromodulation + Conventional physical therapy | Experimental | Patients in this group will receive Trans-spinal Electromagnetic Neuromodulation + Conventional physical therapy Receives: Other: Trans-spinal Electromagnetic Neuromodulation; Other: Conventional physical therapy |
| Conventional physical therapy | Active comparator | Patients in this group will receive Conventional physical therapy Receives: Other: Conventional physical therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain
Numeric Pain Rating Scale (0-10)
Measured: Change from Baseline pain at 6 weeks
Disability
Oswestry disability index (0-100%)
Measured: Change from Baseline disability at 6 weeks
Straight leg raise test
Straight leg raise test
Measured: Change from Baseline straight leg raise test at 6 weeks
H-reflex side-to-side amplitude (H/H) ratio
by EMG unit
Measured: Change from Baseline H-reflex side-to-side amplitude (H/H) ratio at 6 weeks
Sensory tactile threshold
by EMG unit
Measured: Change from Baseline Sensory tactile threshold at 6 weeks
Motor evoked potential
by EMG unit
Measured: Change from Baseline motor evoked potential at 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Aug 2026
- Study start10 Sep 2026
- Primary completion10 Sep 2026
- Study completion10 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lumbar RadiculopathyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Yara Aboelazm Abd Elaziz Mohamed
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Yara Aboelazm Abd Elaziz Mohamed, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07743424
- Sponsor's protocol ID
- P.T.REC/012/006467
- Status last verified
- Sep 2026
- First submitted
- 29 Jul 2026
- Last updated
- 11 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided